Donation

Donate
Myeloma Minute

Case Study #1: Asymptomatic Smoldering Myeloma 

Joseph D. Tariman, PhD, ANP-BC
Beth Faiman, PhDc , MSN, APRN-BC, AOCN®

Case Studies in Multiple Myeloma Treatment Best Practices for Nurses presented at:

ONS 2014
NLB Satellite Symposium
May 1, 2014, Anaheim, CA

​

ASCO 2021 Andromeda study update
Subcutaneous daratumumab plus bortezomib, cyclophosphamide, and dexamethasone in patients with newly diagnosed light chain amyloidosis: Updated results from the phase 3 ANDROMEDA study
ASCO 2021
Read more
Text: increased protein after ASCT overlaid on an image of Dr. Durie
Can my myeloma protein slightly increase after an autologous stem cell transplant (ASCT)?
Read more
Previous Post
Is autologous stem cell transplant (ASCT) still recommended ?
Next Post
NLB 2014: Case Studies: Newly Diagnosed Multiple Myeloma, Therapies, Residual Disease

Give Where Most Needed

Learn More